Premium
Tumoricidal effects of Onconase on various tumors
Author(s) -
Lee Intae,
Lee Young H.,
Mikulski Stanislaw M.,
Lee Jihean,
Covone Kenneth,
Shogen Kuslima
Publication year - 2000
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/(sici)1096-9098(200003)73:3<164::aid-jso10>3.0.co;2-2
Subject(s) - in vivo , clonogenic assay , in vitro , cancer research , medicine , pharmacology , pathology , chemistry , biology , biochemistry , microbiology and biotechnology
Background and Objectives The effects of Onconase (Onc) on the tumor growth in vitro and in vivo were examined. Because elevated tumor interstitial fluid pressure (TIFP) is one of the major causes of inadequate drug delivery into solid tumors, we tested if Onc could lower TIFP in solid tumors. Methods We used several assays including a clonogenic assay and a growth delay assay for the determination of anti‐tumoricidal effects of Onc. We also measured Onc‐induced changes in several tumor physiological parameters. Results Onc demonstrated cytotoxic effects in all eight exponentially growing cell lines in vitro. It effectively inhibited the growth of all four transplanted tumors in vivo, and significantly reduced TIFP in all four tumors. Onc also induced increases in tumor blood flow (TBF) as well as increases in median tumor oxygen partial pressure (pO 2 ) in solid tumors. Conclusions Onc showed anti‐tumoral effects on various tumor cells in vitro as well as in vivo. We also gained some insight regarding the potential physiological benefit of Onc as a new therapeutic agent in cancer treatment. Due to increases in both TBF and tumor pO 2 , Onc could be a potential candidate as a novel radiation enhancer; therefore, the study of the radiation response in vivo is warranted. J. Surg. Oncol. 2000;73:164–171. © 2000 Wiley‐Liss, Inc.